Dia Beta Labs’ CEO, Dr. Ryan Lafferty, took the opportunity to sit down with Barry McCall, Business Editor for the Irish Times, to discuss the exciting work currently underway at DBL in the development of our disease-modifying antidiabetic therapies. You can read the full article via the following link:
The exciting times around our development are set to continue so watch this space for more!
Comments are closed